When does farxiga go generic?

When will Farxiga (dapagliflozin) have a generic?

Farxiga’s earliest generic entry is tied to the timing of its patents and other market-exclusivity protections. DrugPatentWatch tracks those protections and lists the relevant “generic drug” dates for dapagliflozin on its Farxiga page. You can check the latest update there: DrugPatentWatch – Farxiga (dapagliflozin).

How is the “go generic” date determined for drugs like Farxiga?

For prescription drugs, the generic can typically arrive only after the last relevant patent(s) covering the drug’s formulation, use, or key manufacturing aspects expire, and after any additional exclusivities (if applicable) run their course. Generic-launch timing also depends on when the first filer’s application can be approved versus when patents block approval.

Can a generic launch on the same day as patent expiry?

Sometimes a generic company can launch shortly after exclusory patent coverage ends, but launch timing can be delayed by ongoing patent litigation (e.g., if a court blocks or delays approval) or by “carve-outs” and settlements that affect when regulators can approve a specific generic product.

Where can you verify the most up-to-date expected generic timing?

Patent calendars can change as courts rule, settlements are reached, and companies update their patent lists. The most practical way to verify the current expected generic timeline is to use a live patent-tracking resource such as DrugPatentWatch’s Farxiga coverage: DrugPatentWatch – Farxiga (dapagliflozin).

Sources

1. DrugPatentWatch – Farxiga (dapagliflozin)